Parkinson’s Patients Report Treatment of Tremors/Shaking and Balance/Coordination as Primary Unmet Needs, According to Study by GfK Market Measures
Oct. 1, 2008 — Parkinson’s disease patients cite efficacy in treating tremors/shaking, which is experienced across all levels of Parkinson’s severity, as well as the effective treatment of balance/coordination problems as the primary unmet needs among existing therapies on the market, according to new research by GfK Market Measures.
more >>
Hypertensive Patients Forced to Choose Medications Over Groceries in Face of High Co-Pays, According to Study by GfK Market Measures
Sept. 30, 2008 — Hypertensive patients are feeling the impact of rising co-pays for prescription medications and many are compensating for the increased costs by surrendering not only luxury items such as vacations but also necessities such as groceries, according to new research by GfK Market Measures.
more >>
Western European Diabetes Market Shows Movement to Exclusive Pill Therapy, According to Study by GfK Market Measures’ Roper Global Diabetes Group
Sept. 2, 2008 — For diabetes patients across the Western European countries of France, Germany, Italy, the Netherlands, Spain and the United Kingdom, exclusive pill therapy is increasingly the treatment of choice. And while the proportion of patients receiving no medication continues to decline, the use of insulin within the diabetes population remains relatively stable, according to new research from GfK Market Measures’ Roper Global Diabetes Group.
more >>
Specialists Report Decreasing Use of Combination Therapy in Treatment of Alzheimer’s Disease, According to Study by GfK Market Measures
Aug. 29, 2008 — Both psychiatrists and primary care physicians prescribed combination therapy to a smaller proportion of mild and moderate Alzheimer’s disease patients in the past year. Usage of the Namenda/Aricept combination, in particular, has seen declines by these physicians, though growth in prescribing each drug independently continues as part of trend toward single drug therapy, according to new research by GfK Market Measures.
more >>
Continued Low Penetration of Biologics in Treatment of Psoriasis Signals Need for Enhanced Education, Safety Data to Help Patients Overcome Concerns, According to Study by GfK Market Measures
August 5, 2008 — Despite the fact biologics are considered to be the most effective option for treating severe cases of psoriasis, they have been unable to gain patients’ favor and penetrate to date as a class, according to new research by GfK Market Measures.
more >>